Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
Apply
TETA 4HCl vs. DPA
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step